AniV8 (pronounced An-i-vate) is designed to become the leading developer of clinical sensor technology recommended by veterinarians to diagnose and monitor common companion animal disease states. AniV8 was officially launched in London on February 25, 2020. AniV8 has been formed to commercialise its first product, a novel approach to measuring the impact of osteoarthritis pain in companion animals by using proprietary algorithms to measure the quality of movement.
Employees: 1-10
Founded date: 2020
Investors 1
| Date | Name | Website |
| - | Irrus Inve... | irrusinves... |
Mentions in press and media 2
| Date | Title | Description |
| 04.10.2021 | AniV8 announces oversubscribed pre-seed funding round | AniV8 announces oversubscribed pre-seed funding round Mon, Oct 04, 2021 14:08 CET Funding will accelerate development of wearable monitor to detect osteoarthritis-related pain in companion animals Backed by experienced seed investors includ... |
| 15.07.2021 | AniV8 appoints Dr. Ellie Virtue as Chief Executive Officer | AniV8 appoints Dr. Ellie Virtue as Chief Executive Officer Thu, Jul 15, 2021 14:21 CET Experienced animal health executive to drive development and commercialization of AniV8’s innovative clinical sensor technology Development phase for fir... |